Ming Xu
About Ming Xu
Ming Xu is an Actuarial Assistant at Transamerica, where he has worked since 2020, focusing on converting UL and DA products from MoSes to AXIS. He holds a Ph.D. in Pharmacology from Vanderbilt University and has extensive experience in actuarial roles and research.
Work at Transamerica
Ming Xu has been employed at Transamerica since 2020 as an Actuarial Assistant. In this role, Xu is involved in converting Universal Life (UL) and Death Benefit (DA) products from MoSes to AXIS. Prior to this position, Xu worked as an Actuarial Analyst at Transamerica from 2019 to 2020 and as an Actuarial Intern in 2018. Xu's contributions include significant involvement in the development of IFRS17 modeling and the Market consistent capital requirement method in AXIS life models.
Education and Expertise
Ming Xu holds a Doctor of Philosophy (Ph.D.) in Pharmacology from Vanderbilt University, which was completed from 2001 to 2006. Xu also earned a Master of Science (MS) in Actuarial Science from The University of Texas at Dallas from 2017 to 2018. Additionally, Xu obtained a Bachelor's degree in Biochemistry and Molecular Biology from Peking University from 1997 to 2001. This educational background provides a strong foundation in both actuarial science and pharmacology.
Background
Before joining Transamerica, Ming Xu worked in various roles in the Dallas/Fort Worth area. Xu served as an Instructor at the University of Texas Southwestern from 2012 to 2017 and as a Postdoctoral Research Fellow from 2006 to 2012. Xu also gained experience as an Actuarial Intern at National Life Group from 2017 to 2018 and worked briefly as a Barista at Starbucks in 2017. This diverse background includes both academic and practical experience in actuarial science and research.
Achievements
Ming Xu has made notable contributions in the actuarial field, particularly in the development of IFRS17 modeling. Xu has also developed the Market consistent capital requirement method in AXIS life models. These achievements reflect a commitment to advancing actuarial practices and methodologies within the industry.